about
Evidence for mitochondrial localization of divalent metal transporter 1 (DMT1)Induction of arachidonate 12-lipoxygenase (Alox15) in intestine of iron-deficient rats correlates with the production of biologically active lipid mediators.DMT1: a mammalian transporter for multiple metals.Isoform specific regulation of divalent metal (ion) transporter (DMT1) by proteasomal degradation.Iron homeostasis in the lung.Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease.Divalent metal transporter 1 (Dmt1) mediates copper transport in the duodenum of iron-deficient rats and when overexpressed in iron-deprived HEK-293 cells.Cellular iron transport.Behavioral activation group therapy for reducing depressive symptoms and improving quality of life: a feasibility studyA pragmatic pilot randomized trial to investigate the effectiveness of behavioural activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial protocol.Lung injury after ozone exposure is iron dependent.Comparison of mammalian cell lines expressing distinct isoforms of divalent metal transporter 1 in a tetracycline-regulated fashion.Divalent metal transporter-1 decreases metal-related injury in the lung.Mitochondria represent another locale for the divalent metal transporter 1 (DMT1).Calcium-channel blockers do not affect iron transport mediated by divalent metal-ion transporter-1Acceptability of the Fitbit in behavioural activation therapy for depression: a qualitative study.A role for divalent metal transporter (DMT1) in mitochondrial uptake of iron and manganese.Loss of rapid transferrin receptor recycling due to a mutation in Sec15l1 in hbd miceEvidence for and consequences of chronic heme deficiency in Belgrade rat reticulocytesDeficiency of globin messenger RNA in reticulocytes of the Belgrade ratDISCUSSION PAPER: GENETIC VARIATION IN THE PRIMARY STRUCTURE OF THE ? CHAIN OF RABBIT HEMOGLOBINDISCUSSION PAPER: INCREASED SYNTHESIS OF ONE TYPE OF GLOBIN CHAIN RESULTING FROM INHIBITING SYNTHESIS OF THE OPPOSITE TYPE
P50
Q24321984-89876D19-DA04-4CAB-AF1B-1DBB513B4F49Q34747465-052FB6A3-A6E3-474A-9C7A-01960F9CE417Q35061952-56BE7777-2B1E-4E0D-98FB-48EAC287EE34Q36383567-0A762146-7665-45A5-9439-A227AEDA32A6Q36455646-153C0841-8E27-45EB-833E-BE6E2E521D4DQ36985218-629F004B-3922-43BC-B6CD-B6506DFD0E18Q37307319-A56E4697-7502-4DCC-B5D7-A270E999A015Q37432492-D6121C24-6F83-40EA-8120-04ABDF808567Q37498397-2CE34E12-8E33-4665-9981-174737E2F485Q37498856-9B74F9ED-4315-4DDE-8C05-E37519E766E3Q40244129-2A9522C4-CD3F-46D4-A9E9-982C5924B513Q40273470-FD37266D-E8C6-4E31-92FA-797AA6364503Q40419041-799AE120-2ADD-47C6-A02C-33AD0C31EBD0Q41277232-99A55D1C-3256-479D-877C-544FEF18BC81Q42772528-8304B6AD-EC3F-467B-B93F-6F3477440842Q47312546-B01359AE-0650-4C75-977F-B4F710EDF742Q49481733-F0FB3B93-EF91-471E-9044-A6CE8EDBC061Q54975383-1D47DC40-B55E-476A-A52A-9F8E2C329943Q54975414-17391F19-6F35-4BDC-AA19-EFCCFC60E17BQ54975425-49CA2B3A-F101-4BBD-ACCE-FEF55FB0D246Q54975429-1677AB01-2167-4BF7-84C2-FA403ED3291BQ54975430-D3AF7929-B364-414E-8057-7D4A46695373
P50
name
Laura M Garrick
@ast
Laura M Garrick
@en
Laura M Garrick
@nl
type
label
Laura M Garrick
@ast
Laura M Garrick
@en
Laura M Garrick
@nl
prefLabel
Laura M Garrick
@ast
Laura M Garrick
@en
Laura M Garrick
@nl